These potentially novel driver genes (CCDC47, GFM2, IRF2BP1, LRRC10B, MICU3, MTCL1, OR51B2, PCDHAC2, PRUNE2, RDX, THBS3, URB2, and ZMYM6) currently have minimal literature describing their relevance in HCC and therefore warrant further investigation. This evidence concerns the gene MICU3 and hepatocellular carcinoma.